Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
The University of Sydney was established in 1850 and is consistently recognised, both locally and internationally, for its outstanding teaching and research excellence. Sydney alumni include Prime Ministers, Governor Generals, Nobel Prize winners and leaders in every field of endeavour. The...
-
of Medical Research. The laboratory specialises in single-cell RNA sequencing, spatial transcriptomics and computational pipelines applied to patient biospecimens to understand the complexity of intestinal
-
Full time, 2 years fixed term position. Located at the School of Chemistry on the Camperdown Campus The project seeks to design and synthesis bioactive peptides targeting the mycobacterial protein
-
ANSTO (Australia), Imperial College London (UK), and Tokamak Energy (UK), is launching a groundbreaking research program focused on developing new materials for compact tokamak reactors. We are recruiting
-
, turbulence-chemistry interactions in flames ranging from fully premixed to stratified and non-premixed, auto-ignition of both gaseous and liquid fuels, spray atomisation, combustion safety in deflagrations
-
Assistant, you will play a crucial role in executing and supporting laboratory experiments, working closely with PhD students, postdocs, and senior researchers. Your responsibilities will include, but are not
-
contribution of 17% superannuation applies. 24 Months Fixed term Part time position until Oct 2027. This postdoctoral position in computational cognitive science and data science offers an exciting opportunity
-
believe everyone has the right to good health. As the oldest and largest health management program in Australia, our School is a pioneer in public health, global health, infectious diseases intelligence
-
) Sydney, in partnership with ANSTO (Australia), Imperial College London (UK), and Tokamak Energy (UK), is launching a groundbreaking research program focused on developing new materials for compact tokamak
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural